After showing early potential, cholesterol medication fenofibrate fails to cut severe symptoms or death in COVID-19 patients, study finds

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial.